These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16672122

  • 1. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
    Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Loblaw A, Pond GR, Emami M, Sugar L, Sweet J, Narod SA.
    Can J Urol; 2006 Apr; 13 Suppl 2():2-10. PubMed ID: 16672122
    [Abstract] [Full Text] [Related]

  • 2. Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
    Nam RK, Toi A, Trachtenberg J, Klotz LH, Jewett MA, Emami M, Sugar L, Sweet J, Pond GR, Narod SA.
    J Urol; 2006 Feb; 175(2):489-94. PubMed ID: 16406978
    [Abstract] [Full Text] [Related]

  • 3. Assessing individual risk for prostate cancer.
    Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW.
    J Clin Oncol; 2007 Aug 20; 25(24):3582-8. PubMed ID: 17704405
    [Abstract] [Full Text] [Related]

  • 4. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S, Koga F, Fujii Y, Saito K, Yamamoto S, Tatokoro M, Yonese J, Kageyama Y, Fukui I, Kihara K.
    Int J Urol; 2008 Dec 20; 15(12):1055-60. PubMed ID: 19054174
    [Abstract] [Full Text] [Related]

  • 5. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 6. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H, Komiya A, Kamiya N, Imamoto T, Kawamura K, Miura J, Suzuki N, Nakatsu H, Hata A, Ichikawa T.
    Urology; 2006 Jan 20; 67(1):131-6. PubMed ID: 16413348
    [Abstract] [Full Text] [Related]

  • 7. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H, Wang X, Ochiai A, Trpkov K, Yilmaz A, Donnelly JB, Davis JW, Troncoso P, Babaian RJ.
    Cancer; 2007 Dec 01; 110(11):2441-7. PubMed ID: 17932909
    [Abstract] [Full Text] [Related]

  • 8. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.
    Int J Urol; 2008 Jul 01; 15(7):598-603. PubMed ID: 18462353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histological diagnosis of prostate cancer in Korean men aged 70-79 years.
    Shim HB, Lee SE, Park HK, Ku JH.
    Jpn J Clin Oncol; 2007 Oct 01; 37(10):782-7. PubMed ID: 17913831
    [Abstract] [Full Text] [Related]

  • 12. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S, Numao N, Okubo Y, Koga F, Yamamoto S, Saito K, Fujii Y, Yonese J, Masuda H, Kihara K, Fukui I.
    Eur Urol; 2008 Sep 01; 54(3):601-11. PubMed ID: 18207312
    [Abstract] [Full Text] [Related]

  • 13. The presence of prostate cancer on saturation biopsy can be accurately predicted.
    Ahyai SA, Isbarn H, Karakiewicz PI, Chun FK, Reichert M, Walz J, Steuber T, Jeldres C, Schlomm T, Heinzer H, Salomon G, Budäus L, Perrotte P, Huland H, Graefen M, Haese A.
    BJU Int; 2010 Mar 01; 105(5):636-41. PubMed ID: 20149204
    [Abstract] [Full Text] [Related]

  • 14. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
    Eggener SE, Roehl KA, Catalona WJ.
    J Urol; 2005 Aug 01; 174(2):500-4. PubMed ID: 16006880
    [Abstract] [Full Text] [Related]

  • 15. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
    Benecchi L, Pieri AM, Melissari M, Potenzoni M, Pastizzaro CD.
    J Urol; 2008 Jul 01; 180(1):146-9. PubMed ID: 18485383
    [Abstract] [Full Text] [Related]

  • 16. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI.
    BJU Int; 2006 Oct 01; 98(4):788-93. PubMed ID: 16796698
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
    Yanke BV, Gonen M, Scardino PT, Kattan MW.
    J Urol; 2005 Feb 01; 173(2):421-4. PubMed ID: 15643192
    [Abstract] [Full Text] [Related]

  • 19. Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test.
    Optenberg SA, Clark JY, Brawer MK, Thompson IM, Stein CR, Friedrichs P.
    Urology; 1997 Nov 01; 50(5):665-72. PubMed ID: 9372872
    [Abstract] [Full Text] [Related]

  • 20. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH, Roobol MJ.
    Curr Opin Urol; 2009 May 01; 19(3):227-31. PubMed ID: 19357513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.